It also does not increase ghrelin levels in the body, so it does not cause side effects such as increased hunger
One 2023 study found approximately 40% of smokers reported quitting within six months of starting semaglutide, but rigorous randomized controlled trials are still needed
Rising prescription volumes, broader reimbursement coverage, and expanding global market penetration continue to reinforce semaglutide's leadership
The first week on GLP-1 is a good time to think in bites, not big servings
With gradual dose increases, medical guidance, and regular check-ups, they can experience smoother transitions toward appetite control and better metabolic health
Theyll likely need to adapt pricing, marketing, and real-world evidence strategies to continue pushing payers toward coverage